AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 77 filers reported holding AEVI GENOMIC MEDICINE INC in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $156,000 | -32.8% | 1,066,587 | -31.2% | 0.00% | – |
| Q3 2019 | $232,000 | +15.4% | 1,549,272 | +23.7% | 0.00% | – |
| Q2 2019 | $201,000 | +50.0% | 1,252,050 | +82.6% | 0.00% | – |
| Q1 2019 | $134,000 | -73.6% | 685,553 | -5.5% | 0.00% | – |
| Q4 2018 | $508,000 | -58.2% | 725,793 | -26.4% | 0.00% | – |
| Q3 2018 | $1,214,000 | +12.7% | 986,590 | +1.7% | 0.00% | – |
| Q2 2018 | $1,077,000 | -43.2% | 970,452 | +2.9% | 0.00% | – |
| Q1 2018 | $1,896,000 | +108.1% | 943,084 | +24.1% | 0.00% | – |
| Q4 2017 | $911,000 | -25.0% | 759,857 | -21.2% | 0.00% | – |
| Q3 2017 | $1,214,000 | -7.5% | 963,829 | -2.3% | 0.00% | – |
| Q2 2017 | $1,312,000 | -43.1% | 986,707 | -20.4% | 0.00% | – |
| Q1 2017 | $2,305,000 | -61.5% | 1,239,425 | +7.2% | 0.00% | – |
| Q4 2016 | $5,987,000 | – | 1,155,752 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,070,000 | $1,990,000 | 0.99% |
| 22NW, LP | 155,000 | $288,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 405,000 | $753,000 | 0.15% |
| Broadfin Capital, LLC | 500,000 | $930,000 | 0.11% |
| DLD Asset Management, LP | 237,100 | $438,000 | 0.07% |
| Birchview Capital, LP | 68,000 | $126,000 | 0.07% |
| CARL DOMINO INC | 33,273 | $62,000 | 0.07% |
| R&F Capital Advisors LP | 84,268 | $157,000 | 0.04% |
| TFS CAPITAL LLC | 49,461 | $92,000 | 0.03% |
| SIMON QUICK ADVISORS, LLC | 24,390 | $45,000 | 0.03% |